MicroRNAs in pregnancy and gestational diabetes: origin and functions for clinical applications

妊娠和妊娠糖尿病中的 MicroRNA：临床应用的起源和功能

• 批准号: 370695
• 负责人: Bouchard Luigi
• 金额: $ 33.16万
• 依托单位: Universit de Sherbrooke
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2017
• 资助国家: 加拿大
• 起止时间: 2017-09-01 至 2020-09-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=370695&lang=en
• 关键词: Child And Youth Health; Early Screening/Diagnostic; Foetal Metabolic Programming; Gestational Hyperglycemia And Diabetes; Maternal Health In Pregnancy; Microrna; Microrna-Sequencing; Transcriptomics

Gestational diabetes is a condition diagnosed between the 24th and 28th weeks of pregnancy. It comes from a problem about how sugar is transported into cells. This condition affects up to 26% of pregnancies. It may increase the risk of complications. Ther

妊娠期糖尿病是在怀孕 24 至 28 周之间诊断出的一种疾病。它来自于糖如何运输到细胞中的问题。这种情况影响高达 26% 的怀孕。它可能会增加并发症的风险。瑟尔